Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of olesoxime in spinal muscular atrophy
DRKS00000814Phase 2Active, not recruiting
- Sponsor
- Trophos
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, randomised, double-blind trial in spinal muscular atrophy (SMA) comparing Olesoxime with Placebo (2 arms). Started Jun 2011; status: active, not recruiting.
02
Drugs
olesoxime
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on DRKS00000814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000814.